These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35237066)

  • 1. Immune-Related lncRNA Pairs Clinical Prognosis Model Construction for Hepatocellular Carcinoma.
    Zhu Y; Shan D; Guo L; Chen S; Li X
    Int J Gen Med; 2022; 15():1919-1931. PubMed ID: 35237066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-Related lncRNA Signature for Predicting the Immune Landscape of Head and Neck Squamous Cell Carcinoma.
    Yin J; Li X; Lv C; He X; Luo X; Li S; Hu W
    Front Mol Biosci; 2021; 8():689224. PubMed ID: 34327215
    [No Abstract]   [Full Text] [Related]  

  • 3. Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma.
    Deng M; Lin JB; Zhao RC; Li SH; Lin WP; Zou JW; Wei W; Guo RP
    BMC Cancer; 2021 Dec; 21(1):1347. PubMed ID: 34923955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the Survival and Immune Landscape of Colorectal Cancer Patients Using an Immune-Related lncRNA Pair Model.
    Ma C; Zhang X; Zhao X; Zhang N; Zhou S; Zhang Y; Li P
    Front Genet; 2021; 12():690530. PubMed ID: 34552614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a new immune-related lncRNA model and prediction of treatment and survival prognosis of human colon cancer.
    Liu S; Peng X; Wu X; Bu F; Yu Z; Zhu J; Luo C; Zhang W; Liu J; Huang J
    World J Surg Oncol; 2022 Mar; 20(1):71. PubMed ID: 35249533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
    Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
    Front Immunol; 2021; 12():719175. PubMed ID: 34603293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
    Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG
    Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel immune-related lncRNA pair signature for prognostic prediction and immune response evaluation in gastric cancer: a bioinformatics and biological validation study.
    Wang J; Wang B; Zhou B; Chen J; Qi J; Shi L; Yu S; Chen G; Kang M; Jin X; Wang L; Xu J; Zhu L; Chen J
    Cancer Cell Int; 2022 Feb; 22(1):69. PubMed ID: 35144613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature.
    Qi X; Chen G; Chen Z; Li J; Chen W; Lin J; Lin L
    Int J Gen Med; 2021; 14():4279-4289. PubMed ID: 34421308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma.
    Xu Q; Wang Y; Huang W
    Int Immunopharmacol; 2021 Mar; 92():107333. PubMed ID: 33486322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Validation of a Prognostic Prediction Model of m6A Regulator-Related LncRNAs in Hepatocellular Carcinoma.
    Jin C; Li R; Deng T; Li J; Yang Y; Li H; Chen K; Xiong H; Chen G; Wang Y
    Front Mol Biosci; 2021; 8():784553. PubMed ID: 34988119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the immune landscape of invasive breast carcinoma based on the novel signature of immune-related lncRNA.
    Shen S; Chen X; Hu X; Huo J; Luo L; Zhou X
    Cancer Med; 2021 Sep; 10(18):6561-6575. PubMed ID: 34378851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Prognosis and Therapeutic Response Model of Immune-Related lncRNA Pairs in Clear Cell Renal Cell Carcinoma.
    Wang G; Liu P; Li J; Jin K; Zheng X; Xie L
    Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma.
    Chen L; Cai Z; Lyu K; Cai Z; Lei W
    Bioengineered; 2021 Dec; 12(1):2311-2325. PubMed ID: 34167440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using immune-related lncRNAs to construct novel biomarkers and investigate the immune landscape of breast cancer.
    Qin M; Ma Y; Wang Z; Fang D; Wei J
    Transl Cancer Res; 2021 Jun; 10(6):2991-3003. PubMed ID: 35116607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
    Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
    Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma.
    Bu X; Ma L; Liu S; Wen D; Kan A; Xu Y; Lin X; Shi M
    Cancer Cell Int; 2022 Feb; 22(1):95. PubMed ID: 35193591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients.
    Huang S; Zhang J; Lai X; Zhuang L; Wu J
    Front Mol Biosci; 2021; 8():781307. PubMed ID: 35004851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.